Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Human Normal Immunoglobulin market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Human Normal Immunoglobulinmarket, defines the market attractiveness level of Human Normal Immunoglobulin market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Human Normal Immunoglobulin industry, describes the types of Human Normal Immunoglobulin market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human Normal Immunoglobulin market and the development prospects and opportunities of Human Normal Immunoglobulin industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human Normal Immunoglobulin market in Chapter 13.
By Player:
Kamada
Sichuan Yuanda Shuyang
Grifols
Kedrion
Biotest
Emergent (Cangene)
CSL Behring
CNBG
ADMA Biologics
Hualan Bio
CBPO
Shanghai RAAS
By Type:
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Others
By End-User:
Government Institutions
Private Sector
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Human Normal Immunoglobulin Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Human Normal Immunoglobulin Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Human Normal Immunoglobulin Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Human Normal Immunoglobulin Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Human Normal Immunoglobulin Market Analysis and Outlook to 2022
-
7.1 Global Human Normal Immunoglobulin Consumption (2017-2022)
-
7.2 United States Human Normal Immunoglobulin Consumption (2017-2022)
-
7.3 Europe Human Normal Immunoglobulin Consumption (2017-2022)
-
7.4 China Human Normal Immunoglobulin Consumption (2017-2022)
-
7.5 Japan Human Normal Immunoglobulin Consumption (2017-2022)
-
7.6 India Human Normal Immunoglobulin Consumption (2017-2022)
-
7.7 South Korea Human Normal Immunoglobulin Consumption (2017-2022)
8 Region and Country-wise Human Normal Immunoglobulin Market Analysis and Outlook to 2028
-
8.1 Global Human Normal Immunoglobulin Consumption Forecast (2022-2028)
-
8.2 United States Human Normal Immunoglobulin Consumption Forecast (2022-2028)
-
8.3 Europe Human Normal Immunoglobulin Consumption Forecast (2022-2028)
-
8.4 China Human Normal Immunoglobulin Consumption Forecast (2022-2028)
-
8.5 Japan Human Normal Immunoglobulin Consumption Forecast (2022-2028)
-
8.6 India Human Normal Immunoglobulin Consumption Forecast (2022-2028)
-
8.7 South Korea Human Normal Immunoglobulin Consumption Forecast (2022-2028)
9 Global Human Normal Immunoglobulin Market Outlook by Types and Applications to 2022
-
9.1 Global Human Normal Immunoglobulin Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Hepatitis B Immunoglobulins Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Rabies Immunoglobulins Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Tetanus Immunoglobulins Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Human Normal Immunoglobulin Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Government Institutions Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Private Sector Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Human Normal Immunoglobulin Market Outlook by Types and Applications to 2028
-
10.1 Global Human Normal Immunoglobulin Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Hepatitis B Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Rabies Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Tetanus Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Human Normal Immunoglobulin Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Government Institutions Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Private Sector Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Human Normal Immunoglobulin Import and Export Analysis (Top 5 Countries)
-
11.1 Global Human Normal Immunoglobulin Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Human Normal Immunoglobulin Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Human Normal Immunoglobulin Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Human Normal Immunoglobulin Market Competitive Analysis
-
14.1 Kamada
-
14.1.1 Kamada Company Details
-
14.1.2 Kamada Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Kamada Human Normal Immunoglobulin Product and Service
-
14.2 Sichuan Yuanda Shuyang
-
14.2.1 Sichuan Yuanda Shuyang Company Details
-
14.2.2 Sichuan Yuanda Shuyang Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sichuan Yuanda Shuyang Human Normal Immunoglobulin Product and Service
-
14.3 Grifols
-
14.3.1 Grifols Company Details
-
14.3.2 Grifols Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Grifols Human Normal Immunoglobulin Product and Service
-
14.4 Kedrion
-
14.4.1 Kedrion Company Details
-
14.4.2 Kedrion Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Kedrion Human Normal Immunoglobulin Product and Service
-
14.5 Biotest
-
14.5.1 Biotest Company Details
-
14.5.2 Biotest Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Biotest Human Normal Immunoglobulin Product and Service
-
14.6 Emergent (Cangene)
-
14.6.1 Emergent (Cangene) Company Details
-
14.6.2 Emergent (Cangene) Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Emergent (Cangene) Human Normal Immunoglobulin Product and Service
-
14.7 CSL Behring
-
14.7.1 CSL Behring Company Details
-
14.7.2 CSL Behring Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 CSL Behring Human Normal Immunoglobulin Product and Service
-
14.8 CNBG
-
14.8.1 CNBG Company Details
-
14.8.2 CNBG Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 CNBG Human Normal Immunoglobulin Product and Service
-
14.9 ADMA Biologics
-
14.9.1 ADMA Biologics Company Details
-
14.9.2 ADMA Biologics Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 ADMA Biologics Human Normal Immunoglobulin Product and Service
-
14.10 Hualan Bio
-
14.10.1 Hualan Bio Company Details
-
14.10.2 Hualan Bio Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Hualan Bio Human Normal Immunoglobulin Product and Service
-
14.11 CBPO
-
14.11.1 CBPO Company Details
-
14.11.2 CBPO Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 CBPO Human Normal Immunoglobulin Product and Service
-
14.12 Shanghai RAAS
-
14.12.1 Shanghai RAAS Company Details
-
14.12.2 Shanghai RAAS Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Shanghai RAAS Human Normal Immunoglobulin Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Human Normal Immunoglobulin
-
Figure Human Normal Immunoglobulin Picture
-
Table Global Human Normal Immunoglobulin Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Normal Immunoglobulin Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Normal Immunoglobulin Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Human Normal Immunoglobulin Consumption by Country (2017-2022)
-
Figure United States Human Normal Immunoglobulin Consumption and Growth Rate (2017-2022)
-
Table Europe Human Normal Immunoglobulin Consumption and Growth Rate (2017-2022)
-
Figure China Human Normal Immunoglobulin Consumption and Growth Rate (2017-2022)
-
Figure Japan Human Normal Immunoglobulin Consumption and Growth Rate (2017-2022)
-
Figure India Human Normal Immunoglobulin Consumption and Growth Rate (2017-2022)
-
Figure South Korea Human Normal Immunoglobulin Consumption and Growth Rate (2017-2022)
-
Figure Global Human Normal Immunoglobulin Consumption Forecast by Country (2022-2028)
-
Figure United States Human Normal Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Human Normal Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Human Normal Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Human Normal Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Human Normal Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Human Normal Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis B Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Global Rabies Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Global Tetanus Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Government Institutions Consumption and Growth Rate (2017-2022)
-
Figure Global Private Sector Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis B Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rabies Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tetanus Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Government Institutions Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Private Sector Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Human Normal Immunoglobulin Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Human Normal Immunoglobulin Export by Region (Top 5 Countries) (2017-2028)
-
Table Kamada (Foundation Year, Company Profile and etc.)
-
Table Kamada Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kamada Human Normal Immunoglobulin Product and Service
-
Table Sichuan Yuanda Shuyang (Foundation Year, Company Profile and etc.)
-
Table Sichuan Yuanda Shuyang Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sichuan Yuanda Shuyang Human Normal Immunoglobulin Product and Service
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Human Normal Immunoglobulin Product and Service
-
Table Kedrion (Foundation Year, Company Profile and etc.)
-
Table Kedrion Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kedrion Human Normal Immunoglobulin Product and Service
-
Table Biotest (Foundation Year, Company Profile and etc.)
-
Table Biotest Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biotest Human Normal Immunoglobulin Product and Service
-
Table Emergent (Cangene) (Foundation Year, Company Profile and etc.)
-
Table Emergent (Cangene) Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emergent (Cangene) Human Normal Immunoglobulin Product and Service
-
Table CSL Behring (Foundation Year, Company Profile and etc.)
-
Table CSL Behring Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Behring Human Normal Immunoglobulin Product and Service
-
Table CNBG (Foundation Year, Company Profile and etc.)
-
Table CNBG Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table CNBG Human Normal Immunoglobulin Product and Service
-
Table ADMA Biologics (Foundation Year, Company Profile and etc.)
-
Table ADMA Biologics Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table ADMA Biologics Human Normal Immunoglobulin Product and Service
-
Table Hualan Bio (Foundation Year, Company Profile and etc.)
-
Table Hualan Bio Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hualan Bio Human Normal Immunoglobulin Product and Service
-
Table CBPO (Foundation Year, Company Profile and etc.)
-
Table CBPO Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table CBPO Human Normal Immunoglobulin Product and Service
-
Table Shanghai RAAS (Foundation Year, Company Profile and etc.)
-
Table Shanghai RAAS Human Normal Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai RAAS Human Normal Immunoglobulin Product and Service
-
